Pmv Depreciation And Amortization from 2010 to 2025
| PMVP Stock | USD 0.88 0.02 2.22% |
Depreciation And Amortization | First Reported 2019-03-31 | Previous Quarter 371 K | Current Value 39 K | Quarterly Volatility 136.5 K |
Check Pmv Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pmv Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 11.2 M, Interest Income of 11.2 M or Depreciation And Amortization of 639.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.46. Pmv financial statements analysis is a perfect complement when working with Pmv Pharmaceuticals Valuation or Volatility modules.
Pmv | Depreciation And Amortization | Build AI portfolio with Pmv Stock |
Latest Pmv Pharmaceuticals' Depreciation And Amortization Growth Pattern
Below is the plot of the Depreciation And Amortization of Pmv Pharmaceuticals over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. Pmv Pharmaceuticals' Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pmv Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Depreciation And Amortization | 10 Years Trend |
|
Depreciation And Amortization |
| Timeline |
Pmv Depreciation And Amortization Regression Statistics
| Arithmetic Mean | 463,131 | |
| Geometric Mean | 409,749 | |
| Coefficient Of Variation | 64.51 | |
| Mean Deviation | 206,338 | |
| Median | 338,000 | |
| Standard Deviation | 298,744 | |
| Sample Variance | 89.2B | |
| Range | 950K | |
| R-Value | 0.58 | |
| Mean Square Error | 63.5B | |
| R-Squared | 0.34 | |
| Significance | 0.02 | |
| Slope | 36,367 | |
| Total Sum of Squares | 1.3T |
Pmv Depreciation And Amortization History
About Pmv Pharmaceuticals Financial Statements
Pmv Pharmaceuticals shareholders use historical fundamental indicators, such as Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Although Pmv Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Pmv Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Pmv Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Depreciation And Amortization | 1.1 M | 639.1 K |
Additional Tools for Pmv Stock Analysis
When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.